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Background: Left ventricular noncompaction (LVNC) describes deep trabeculations in the left ventricular (LV)
endocardium and a thinned epicardium. LVNC is seen both as a primary cardiomyopathy and as a secondary
finding in other syndromes affecting the myocardium such as neuromuscular disorders. The objective of this study
is to define the prevalence of LVNC in the Duchenne Muscular Dystrophy (DMD) population and characterize its
relationship to global LV function.
Methods: Cardiac magnetic resonance (CMR) was used to assess ventricular morphology and function in 151
subjects: DMD with ejection fraction (EF) > 55% (n = 66), DMD with EF < 55% (n = 30), primary LVNC (n = 15) and
normal controls (n = 40). The non-compacted to compacted (NC/C) ratio was measured in each of the 16 standard
myocardial segments. LVNC was defined as a diastolic NC/C ratio > 2.3 for any segment.
Results: LVNC criteria were met by 27/96 DMD patients (prevalence of 28%): 11 had an EF > 55% (prevalence of
16.7%), and 16 had an EF < 55% (prevalence of 53.3%). The median maximum NC/C ratio was 1.8 for DMD with
EF > 55%, 2.46 for DMD with EF < 55%, 1.54 for the normal subjects, and 3.69 for primary LVNC patients.
Longitudinal data for 78 of the DMD boys demonstrated a mean rate of change in NC/C ratio per year of +0.36.
Conclusion: The high prevalence of LVNC in DMD is associated with decreased LV systolic function that develops
over time and may represent muscular degeneration versus compensatory remodeling.
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Left ventricular noncompaction (LVNC) is character-
ized by deep trabeculations in the left ventricular (LV)
endocardium. The LVNC phenotype has been described
in several genetically mediated diseases including the
alpha-dystrobrevin mutation, mitochondrial mutations,
and Cypher/ZASP mutation [1,2]. In this setting, LVNC
has been thought to be a primary process resulting from
arrest in normal myocardial compaction during human
embryonic development between weeks 5–8 [3]. LVNC
has been associated with other cardiac phenotypes,
including LV hypertrophy, LV dilation and combined LV
hypertrophy and dilation. LVNC has been described in
genetic disorders with cardiac involvement, e.g. G4.5
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reproduction in any medium, provided the or(DMD) [4-6]. The extent to which LVNC is a primary
defect or is a secondary, compensatory process in these
genetic disorders remains unclear [7,8].
Patients with DMD, a lethal X-linked skeletal and car-
diac myopathy caused by dystrophin mutations, univer-
sally develop cardiac dysfunction [9]. Echocardiography is
used to assess function in younger DMD patients; how-
ever, due to poor windows, cardiac magnetic resonance
imaging (CMR) is used to monitor function in older pa-
tients. CMR is also a sensitive tool for the diagnosis of
LVNC [10-16]. In the course of performing several hun-
dred DMD cardiac MR studies, a marked prevalence of
LVNC was noted. This study aimed to define the preva-
lence of LVNC in DMD patients and characterize its rela-
tionship to global LV function using CMR. LVNC imaging
criteria were used to evaluate the extent of LVNC in these
studies. Specific CMR criteria for LVNC have been pro-
posed, but there are no universally accepted guidelines.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Example of measurement of noncompacted:
compacted ratio in the short axis view of CMR of a
DMD patient.
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Data was analyzed from records of patients with DMD
or LVNC followed at Cincinnati Children’s Hospital
Medical Center (IRB). The diagnosis of DMD was con-
firmed by skeletal muscle biopsy in all patients. The
diagnosis of LVNC was made clinically based on ac-
cepted non-invasive imaging criteria. All DMD or LVNC
patients that underwent CMR between 2005 and 2010
were included. An age-matched control group of sub-
jects with completely normal CMR finding was also ana-
lyzed. For patients with more than one CMR study, the
most recent study was used for the primary analysis.
Serial data was evaluated for all DMD patients with mul-
tiple CMR studies. The study was approved by our Insti-
tutional Review Board.
Imaging protocols
All CMR studies were performed according to standard
clinical protocol. Studies included standard cardiac func-
tional imaging using a retrospective vectorcardiographic
(VCG)-gated segmented steady-state free precession
(SSFP) sequence. Patients were imaged on both a Sie-
mens Avanto 3 T and GE 1.5 T magnets. A 3 T standard
imaging was preceded by frequency scouting and adjust-
ment. Subjects were breath-held as tolerated. For those
subjects who could not adequately breath-hold, a free
breathing technique with multiple signal averages was
used. Standard functional imaging included a short-axis
stack of cine SSFP images from cardiac base to apex.
The short axis was prescribed as the perpendicular plane
to the LV long axis in 2- and 4-chamber views as previ-
ously described [17,18]. Typical scan parameters included
field of view 32 to 38 cm, slice thickness 5 mm, echo
time/repetition time(TE/TR) 1.4/2.8 (Siemens Medical
Solutions), TE/TR 2.0/4.0 (GE Healthcare), and in-plane
resolution was 1.5 mm. A minimum of 12 slices were
performed, with 24 phases/slice. The typical temporal
resolution of the cine SSFP images was 30 to 40 ms, and
was adjusted according to the patient’s heart rate and abil-
ity to breath-hold. Myocardial Delayed Enhancement
(MDE) Imaging was performed when intravenous (IV)
access was obtained; at our center, IV access is routinely
obtained in all DMD subjects if possible, though in DMD
subjects < 10 years of age, IV gadolinium is deferred if suc-
cessful IV placement requires more than 1 venipuncture
attempt. MDE imaging was performed via a gradient echo
inversion sequence recovery protocol 10 min after
0.2 mmol/kg gadolinium diethylenetriamine penta-aceticacid (Gd-DTPA) injection. MDE imaging was consid-
ered positive if any area of the myocardium showed
hyperenhancement as assessed by consensus of 2 inde-
pendent expert observers.Global functional data
Ventricular volumes, mass, and global function were
assessed via standard planimetry with a semi-automated
technique (QMASS version 6.1.5, Medis Medical Im-
aging Systems, Leiden, the Netherlands) [19,20]. This
assessment was performed on images from either scan-
ner, independent of vendor or field strength [21]. Late
gadolinium enhancement (LGE) status for each segment,
ventricular volumes, mass, and EF were tabulated for
each subject and then exported to a RedCap database.LVNC assessment
The LVNC status was assessed according to a standard
metric previously described [14]. Using a high fidelity
digital ruler within AMICAS PACS, the non-compacted
to compacted ratio (NC/C) was measured in all 16 seg-
ments according to the AHA 16 segment model. The
apical cap was not included in the assessment. All mea-
surements were made by the primary investigator. The
myocardium was considered to be positive for LVNC if
the noncompacted to compacted ratio was greater than
2.3:1 in diastole in one segment as described by Petersen
et al. [14]. A similar technique was used by Dawson et al.
in a study describing the characteristics of compacted and
non-compacted ratios [22] (Figure 1). The maximal NC/C
ratio was defined as the largest NC/C in any segment.
Care was taken to avoid areas of multihead attachment of
the papillary muscles to the left ventricle [23].
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Three of the patients enrolled in the study (1 DMD and
2 primary LVNC) had specimens available for image
correlation. The DMD patient underwent placement of a
HeartMate left ventricular assist device and both pri-
mary LVNC patients underwent orthotopic heart trans-
plantation. An experienced pathologist analyzed the
specimens for the presence and extent of LVNC.
Statistical analysis
Prevalence of LVNC was compared using a Chi-Square
test and prevalence for each group was estimated using a
95% Wald confidence interval for proportions. Spearman’s
Rank correlation was used to determine association be-
tween the left ventricular end diastolic volume Z-score
and NC/C ratio. Median ratios were compared using the
Wilcoxon Rank-Sum test when two groups were present
and the Kruskal-Wallis test for more than two. Inter- and
intra- observer agreement was measured using the
intraclass correlation coefficient (ICC). These values range
from 0 to 1, with 0.0-0.2 indicating very little agreement,
0.2-0.4 little agreement, 0.4-0.6 moderate agreement,
0.6-0.8 strong agreement, and 0.8-1.0 very strong agree-
ment. For all tests, a p-value of < 0.05 was considered sta-
tistically significant. Corrections for multiple comparisons
were made using the Bonferroni method. All analyses




There were a total of 151 subjects enrolled; DMD (n =
96), normal control (n = 40) and primary LVNC (n = 15).
A total of 229 CMR studies were evaluated including 78
serial DMD studies. There were 96 DMD boys: EF > 55%
(n = 66) and EF < 55% (n = 30). All 40 normal control
subjects had an EF > 55%. Of the 15 patients with pri-
mary LVNC, 6 had an EF < 55% and 9 with an EF > 55%.
The median ages of the groups are included in Table 1.
LVNC in DMD
Among the 96 DMD boys, there were 27 cases meeting
the LVNC criterion, with an overall prevalence of 28%
(95% CI = 19.1% - 37.1%, p < 0.0001). Of the 27 LVNC
cases in DMD boys, 11 had an EF > 55%, and 16 with an
EF < 55%. The prevalence of LVNC in DMD boys withTable 1 Demographic data of the study population
Group Total number Median age # Male (%)
DMD with EF >55% 66 13.7 66 (100)
DMD with EF <55% 30 15.1 30 (100)
Primary LVNC 15 17.6 8 (53.3)
Normal 40 16 22 (55)EF > 55% was 16.7% (95% = 6.8% - 26.6%) compared to
53.3% (95% = 35.4% - 71.2%) for DMD boys with EF < 55%
(p = 0.0002). No normal subject had evidence of LVNV or
an NC/C ratio > 2.3 in any segment.
Particular LV segments that were positive for LVNC
with a NC/C ratio > 2.3 were in similar locations in pa-
tients with DMD with EF > 55%, DMD with EF < 55% or
LVNC. In all the subjects, the apical segments were
more likely to have ratios > 2.3 with segment 16 being
the most common segment to be positive. Segment 16
was positive in 73% of the primary LVNC patients, 40%
of DMD subjects with an EF < 55%, and 9.1% of DMD
subjects with an EF > 55%. The segments most com-
monly positive in the LVNC population were apical
segments 13, 15 and 16. In the DMD population, it was
segments 11,12 and 16. These segments correspond to
the segments that have been described to have scar tis-
sue burden with LGE analysis [24] (Figure 2).
Consistent with the previous data which suggests that
there is a higher prevalence of LVNC in the DMD boys
with decreased function, there was a correlation between
left ventricular end diastolic volume Z- score and NC/C
ratio (Figure 3). The relationship was linear with an
r = 0.40 (p <0.0001). As the left ventricular end diastolic
volume z-score increased so did the NC/C ratio.
The median NC/C ratios with interquartile ranges
were calculated for each of the groups. The median
maximal NC/C ratio was 1.8 (IQR 1.57, 2.02) for DMD
boys with EF > 55% compared to 1.54 (IQR 1.29, 1.78)
for the normal group (p < 0.0001). For DMD boys with
EF < 55% median maximal NC/C ratio was 2.46 (IQR
1.84, 3.04) compared to 3.69 (IQR 2.81, 4.23) for the
LVNC group (p < 0.0001) (Figure 4).Figure 2 Distribution of positive segments by patient group.
Segment 16 (apical lateral) in both DMD and LVNC most commonly
fulfilled criteria for LVNC. The apical and lateral segments are more
frequently positive across all groups which is consistent with
previous findings in LVNC. DMD, Duchenne Muscular Dystrophy;
EF, ejection fraction; LVNC, left ventricular non-compaction;
NC, noncompacted length; C, compacted length.
Figure 3 LVED Z-score vs NC/C ratio. There is a linear relationship
with r = 0.40 (p < 0.0001). As the LVED increases the NC/C ratio also
increases. DMD, Duchenne Muscular Dystrophy; LVEDV, left
ventricular end diastolic volume; NC, noncompacted length;
C, compacted length.
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C ratio > 2.3 in any one segment), the mean number of
positive segments was 2.2. This can be compared to the
15 patients with primary LVNC who had a mean of 3.4
positive segments. The median maximal NC/C ratio for
all 27 DMD boys that met criteria for LVNC was 3.0
(IQR 2.61, 3.26).
LGE assessment
The presence of LGE was assessed in 90 of the 96 DMD
boys. LGE was positive for 30 of these 90 DMD boys. Of
the 30 with LGE, 9 (30%) had normal left ventricular
function and 21 (70%) had depressed function. There
were 12 of 30 (40%) with NC/C ratios greater than 2.3.Figure 4 Noncompacted to compacted ratio. This is a box plot
showing the mean (diamond), median (middle vertical line), as well
as interquartile range (end of the boxes) of the highest NC/C ratio
for each population. DMD, Duchenne Muscular Dystrophy; EF, ejection
fraction; LVNC, left ventricular noncompaction; NC, noncompacted
length; C, compacted length.Eleven of the 12 subjects with both LGE and LVNC had
depressed left ventricular function. The segments that
were affected for the 30 with LGE were most commonly
segments 5, 6, 11, 12, and 16. The most common seg-
ments with a NC/C ratio greater than 2.3 were again 11,
12, and 16. In the 12 patients with LGE and LVNC,
there were a total of 30 segments with a NC/C greater
than 2.3, 22 or 73% of these segments were also positive
for LGE. 12 of the 15 patients with primary LVNC had
LGE assessed. There was no evidence of LGE in any of
these 12 patients. None of the normal patents had evi-
dence of LGE.
LVNC in DMD (Analysis of serial studies)
There was longitudinal data available for 78 of the DMD
boys. The median rate of change in NC length per year
was +0.92 mm (IQR 0.34, 2.04). The median rate of
change in C length was −0.36 mm (IQR 0.78, 0). The
median rate of change in NC/C ratio per year was +0.36
(IQR 0.14, 0.68). In DMD patients with serial data avail-
able, the noncompacted layer increased in thickness as
the compacted layer decreased in thickness, leading to
an increase in NC/C ratio (Figures 5, 6, and 7).
Pathologic correlation
All three patients with available pathology were con-
firmed to have LVNC by standard pathologic criteria. An
example myocardial wedge is shown in Figure 8. There
is extensive non-compacted myocardium and relatively
thin areas of compacted myocardium. The DMD patient
showed extensive areas of fibrosis consistent with typical
changes of DMD cardiomyopathy.
Inter/Intra observer variability
Inter-observer and intra-observer variability was measured
on 10% of patients as described above. Intra-observer vari-
ability for NC/C ratio had an ICC mean of 0.68 for all
segments, which indicates a strong agreement. The inter-
observer variability had an ICC mean of 0.97, which indi-
cates a very strong agreement between observers.
Discussion
This study shows a markedly elevated prevalence of
LVNC in a large DMD population with 28% having a
NC/C ratio > 2.3 in at least one cardiac segment. DMD
boys with normal global function have a much lower
prevalence of LVNC than those with decreased systolic
function. There is an increase in the non-compacted
length with a decrease in compacted length over time in
the majority of DMD boys whether or not they met cri-
teria for LVNC.
Several case reports and small case series have found an
association of LVNC with neuromuscular disease. This is
the first study to describe the prevalence of LVNC within
Figure 5 Noncompacted length vs time. This graph shows the progression of noncompacted length over time in all DMD patients that
longitudinal data was available. There is an increase in noncompacted length over time. DMD, Duchenne Muscular Dystrophy; NC, noncompacted
length.
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scribed a cohort of 62 patients with LVNC in which 49
had a full neurological work-up. Remarkably, 40 of these
patients were found to have some type of myopathy [4].
Finsterer et al. described a case of a patient with DMD
who had evidence of LVNC [25].
The phenotypic noncompaction described in this popu-
lation of DMD is much more prevalent than would be
expected in the general population by autopsy or non-Figure 6 Compacted length vs time. This shows the progression of com
available. There is a decrease in compacted length over time. DMD, Ducheinvasive imaging. Boyd et al. described deep trabeculations
in only 4% of 474 normal hearts on autopsy [26]. Kohli
et al. described a cohort of CMRs of those diagnosed with
dilated cardiomyopathy and found that ~24% of them met
criteria for LVNC [27]. There is sparse data about the
prevalence of LVNC diagnosed via echo, and even less in
children. In one adult study there was a 3.7% prevalence of
definite or probable LVNC found in those with LVEF </=
45% and a 0.26% prevalence for all patients referred forpacted length over time in all DMD patients that longitudinal data was
nne Muscular Dystrophy; C, compacted length.
Figure 7 Noncompacted to compacted ratio vs time. This graph shows the progression of NC/C ratio over time in all DMD patients that
longitudinal data was available. There is an increase in NC/C ratio over time. DMD, Duchenne Muscular Dystrophy; NC, noncompacted; C,
compacted length.
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this represents an under-recognized population of those
with LVNC that then develop poor function and dilation
or that it is actually a compensatory mechanism of the fail-
ing ventricle has yet to be seen.Figure 8 Pathologic specimen showing LVNC in a DMD patient.
The image shows a piece of myocardium removed from the apex
during implantation of a left ventricular assist device. There is
extensive noncompacted myocardium extending form the
compacted myocardium in finger-like projections. DMD, Duchenne
Muscular Dystrophy.Although DMD related heart disease has been historic-
ally classified as a dilated cardiomyopathy, it has recently
been described as a unique entity characterized by our
group as left ventricular functional decline without signifi-
cant ventricular dilatation until late in disease progression.
It was shown that despite normal LVRI (left ventricular re-
modeling index), myocardial function assessed by CMR
strain decreases with age [29]. The LVNC associated with
DMD is a progressive phenotype. As DMD associated
cardiac disease progresses, LVNC may develop second-
ary to thinning of the compacted myocardium and
resulting in remodeling that appears as LVNC. This
apparent increase in trabeculations and thinning of the
compacted layer results in an increase in NC/C ratio
(Figures 5, 6 and 7). This pattern of increased trabe-
culation with thinning of the compacted layer seems to
occur in most DMD patients over time, further sup-
porting that this is a progressive phenotypic change
characteristic of the myocardial degradation.
Advanced DMD associated heart disease has also been
described to have thinning and fibrofatty replacement of
the apical and mid- LV free wall with markedly positive
late gadolinium enhancement (LGE) in these segments
on CMR [24,30]. As Figure 2 shows, the segments with
NC/C ratios greater than 2.3 are very similar to those
segments previously described as being positive for LGE.
In our patients, LGE was found in the same segments as
the LVNC as described above. One possible explanation
is that as the compacted tissue scars and thins, the non-
compacted tissue becomes more prominent.
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is also limited by a lack of universal imaging criteria for
the LVNC phenotype. Different criteria for LVNC would
yield slightly different prevalence numbers for this popu-
lation. This group of DMD patients falls in a relatively
narrow age range with no patients less than 7 years of
age and relatively few older patients.
Conclusions
Although these data show that the progression of DMD
associated heart disease includes the development of
LVNC, these patients likely do not have classic primary
LVNC cardiomyopathy. Rather, the changes that occur
late in the disease process are characterized by marked
alteration in myocardial structure secondary to fibrofatty
replacement of myocardial cells and/or a compensatory
mechanism due to cardiac dysfunction. This data defini-
tively shows DMD patients that originally had normal
NC/C ratios later developed trabeculations as the disease
progressed. This may give some insight to the high preva-
lence of noncompacted tissue of those with cardiac dys-
function. It also raises the broader question of whether
LVNC in patients with LVNC cardiomyopathy and dilated
ventricles is a primary or secondary process.
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